Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Teladan Prima Agro Tbk. (TLDN)

Organon Pharma Indonesia Tbk.Trading
Teladan Prima Agro Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Organon Pharma Indonesia Tbk. dan Teladan Prima Agro Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Teladan Prima Agro Tbk. diperdagangkan di Rp615 (kapitalisasi pasar 8,22 T, volume 24 jam 1,81 jt). Perbedaan utamanya: Teladan Prima Agro Tbk. jauh lebih besar — sekitar 78,7× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

SCPITLDN
Kapitalisasi Pasar
104,4 M8,22 T
Volume
1,81 jt
Lot
18,15 rb
Perputaran
1,11 M
Harga Rata-rata
613,91
Nilai Transaksi
1,11 M
Harga Ekuilibrium Indikatif
615
Volume Ekuilibrium Indikatif
19

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

SCPI
Lihat detail
TLDN
Lihat detail

Tentang Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Selengkapnya di halaman SCPI

Tentang Teladan Prima Agro Tbk.

PT Teladan Prima Agro Tbk ( formerly PT Sandaran Prima Sawit ) was established in the Republic of Indonesia on May 10, 2004 based on the Notarial Deed No. 22 of Imas Fatimah, S.H. On May 25, 2012, the Company's shareholders approved the proposed merger with PT Teladan Agro Resources (“TAR”) where the Company is the recipient of the merger (“Penggabungan 2012”).

Selengkapnya di halaman TLDN